Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2024Endocrine JournalOpen Access

Real-world clinical evidence of oral semaglutide on metabolic abnormalities in subjects with type 2 diabetes: a multicenter retrospective observational study (the Sapporo-Oral SEMA study)

View Full Paper
Ask AI
Bookmark
Share

Authors

SFSho FurusawaHokkaido UniversityHNHiroshi NomotoAsahikawa Medical College HospitalCOChiho Oba‐YamamotoHokkaido University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Furusawa et al. (2024) studied this question.

synapsesocial.com/papers/6a8d39cd73c53b5e867aa889https://doi.org/10.1507/endocrj.ej23-0648
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016 · 7,661 citations
  2. 2Review of head‐to‐head comparisons of glucagon‐like peptide‐1 receptor agonists2015 · 303 citations
  3. 3Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide2011 · 765 citations
  4. 4Metabolic memory and all‐cause death in community‐based patients with type 2 diabetes: the Fremantle Diabetes Study2016 · 23 citations
  5. 5Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes2008 · 3,488 citations